Live Quote · NASDAQKPTIHealthcare· Biotechnology

Karyopharm Therapeutics Inc.

$0.02▲ 5.88%(+$0.00)
MKT CAP $408.27KLAST EARNINGS Nov 12, 2026
50%
Bullish
TickerSpark Score
54/100
▌ Mixed
100
Valuation
60
Profitability
25
Growth
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KPTI research report →

Analyst Price Target
$7.33+40622.2% vs. today

Range $3 – $16

Analyst RatingBuy
13 Buy6 Hold2 Sell

Price Chart

-99.48% · this period
$10.67$5.34$0.02Nov 13May 18Nov 16
52-Week Range0% of range
Low
$0.01
Current
$0.02
High
$10.99